Seattle biotech startup Athira raises $85M to develop therapies for Alzheimer’s and Parkinson’s

The Athira team. (Athira Photo)

The foundation of Athira Pharma began while Leen Kawas was earning her Ph.D. in molecular pharmacology at Washington State University nearly a decade ago.

Fast forward to today and the Seattle biotech startup is inching closer to FDA approval for its drug therapy

This post was originally published on this site


Check out